[From acid secretion inhibition to enterochromaffin-like cell proliferation. Traps on the path].
INSERM U10, Hôpital Bichat, Paris.
S J
SJ
Bonfils
D000230:Adenocarcinoma / Q000150:complications / Q000235:genetics; D002276:Carcinoid Tumor / Q000150:complications / Q000235:genetics*; D004759:Enterochromaffin Cells / Q000187:drug effects / Q000473:pathology*; D005753:Gastric Mucosa / Q000187:drug effects / Q000473:pathology*; D005755:Gastrins / Q000097:blood*; D005757:Gastritis, Atrophic / Q000150:complications; D006801:Humans; D009853:Omeprazole / Q000494:pharmacology*; D013274:Stomach Neoplasms / Q000150:complications / Q000235:genetics; D015043:Zollinger-Ellison Syndrome / Q000150:complications
D005755:Gastrins; D009853:Omeprazole
De la réduction sécrétoire acide à la prolifération des cellules enterochromaffin-like. Un chemin jalonné d'embûches.